IP Library Granted Patent US 8,883,481
Granted Patent B2
US 8,883,481 · App. 13/503,353 · Granted Nov 11, 2014

Reverse genetics methods for virus rescue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,481
App. No.
13/503,353
Granted
Nov 11, 2014
Kind
B2
Abstract

A method for rescuing a virus by reverse genetics is provided in which cells are added after transfection.

Claims (8)

1. A method for preparing an influenza virus comprising the steps of (i) transfecting a culture of mammalian kidney cells with at least one expression construct encoding an influenza RNA molecule; (ii) adding untransfected mammalian kidney cells to the transfected cells of step (i) to provide a mixture of cells, wherein the untransfected cells are of the same type as the cells of step (i); and (iii) culturing the mixture of cells from step (ii) in order to produce influenza virus.

2. A method for preparing an influenza virus comprising the steps of (i) transfecting a culture of MDCK cells with at least one expression construct encoding an influenza RNA molecule; (ii) adding untransfected MDCK cells to the transfected MDCK cells of step (i) to provide a mixture of MDCK cells; and (iii) culturing the mixture of MDCK cells in order to produce influenza virus.

3. A method for preparing an influenza virus for vaccine manufacture, comprising steps (i)-(iii) of claim 2 , and further comprising (iv) purifying the virus obtained in step (iii).

4. The method of claim 1 , wherein the mammalian kidney cell is a VERO or MDCK cell.

5. The method of claim 2 , wherein the MDCK cell is the cell line MDCK 33016 (DSM ACC2219).

6. The method of claim 3 , further comprising the step of formulating the virus purified in step (iv) into a vaccine.

7. The method of claim 1 , wherein the cells are cultured in suspension.

8. The method of claim 1 , wherein the cells are cultured adherently.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2016
From: NOVARTIS AG
To: SEQIRUS UK LIMITED
Reel/Frame 039335/0937 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2012
From: KEINER, BJOERN
To: NOVARTIS VACCINES AND DIAGNOSTICS GMBH
Reel/Frame 029152/0831 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2012
From: UHLENDORFF, JENNIFER; MATROSOVICH, MIKHAIL
To: NOVARTIS VACCINES AND DIAGNOSTICS GMBH
Reel/Frame 029122/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2012
From: NOVARTIS VACCINES AND DIAGNOSTICS GMBH
To: NOVARTIS AG
Reel/Frame 029123/0029 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2012
From: DORMITZER, PHILIP; SUPHAPHIPHAT, PIRADA; FRANTI, MICHAEL; MASON, PETER
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 029115/0857 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2012
From: NOVARTIS VACCINES & DIAGNOSTICS, INC.
To: NOVARTIS AG
Reel/Frame 029115/0988 →